New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 10, 2014
08:34 EDTINSVInSite Vision, Senju Pharmaceutical announce collaboration agreement
InSite Vision Incorporated and Senju Pharmaceutical announced that they have entered into a collaboration and license agreement to develop and market InSite’s azithromycin ophthalmic solution using DuraSite including AzaSite 1% and AzaSite XtraTM 2% ocular antibiotics in Japan. Senju has agreed to pay InSite an upfront license fee, additional development milestones fees, and a percentage royalty on net sales.
News For INSV From The Last 14 Days
Check below for free stories on INSV the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for INSV

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use